Skip to menu Skip to content Skip to footer

2021

Journal Article

Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2

Pandey, Manisha, Ozberk, Victoria, Eskandari, Sharareh, Shalash, Ahmed O., Joyce, Michael A., Saffran, Holly A., Day, Christopher J., Lepletier, Ailin, Spillings, Belinda L., Mills, Jamie-Lee, Calcutt, Ainslie, Fan, Fan, Williams, James T., Stanisic, Danielle I., Hattingh, Laetitia, Gerrard, John, Skwarczynski, Mariusz, Mak, Johnson, Jennings, Michael P., Toth, Istvan, Tyrrell, D. Lorne and Good, Michael F. (2021). Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2. Clinical and Translational Immunology, 10 (3) e1260, e1260. doi: 10.1002/cti2.1260

Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2

2018

Journal Article

The relationship between the permeability and the performance of carrier-based dry powder inhalation mixtures: new insights and practical guidance

Shalash, Ahmed O., Khalafallah, Nawal M., Molokhia, Abdulla M. and Elsayed, Mustafa M. A. (2018). The relationship between the permeability and the performance of carrier-based dry powder inhalation mixtures: new insights and practical guidance. AAPS PharmSciTech, 19 (2), 912-922. doi: 10.1208/s12249-017-0898-7

The relationship between the permeability and the performance of carrier-based dry powder inhalation mixtures: new insights and practical guidance

2018

Journal Article

Modeling the performance of carrier-based dry powder inhalation formulations: where are we, and how to get there?

Elsayed, Mustafa M. A. and Shalash, Ahmed O. (2018). Modeling the performance of carrier-based dry powder inhalation formulations: where are we, and how to get there?. Journal of Controlled Release, 279, 251-261. doi: 10.1016/j.jconrel.2018.03.020

Modeling the performance of carrier-based dry powder inhalation formulations: where are we, and how to get there?

2017

Journal Article

A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed

Shalash, Ahmed O. and Elsayed, Mustafa M. A. (2017). A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed. AAPS PharmSciTech, 18 (8), 2862-2870. doi: 10.1208/s12249-017-0767-4

A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed

2017

Conference Publication

Carrier microstructure and performance of dry powder inhalation mixtures: a step towards universal performance prediction model

Shalash, Ahmed O., Khalafallah, Nawal M., Molokhia, Abdulla M. and Elsayed, Mustafa M. A. (2017). Carrier microstructure and performance of dry powder inhalation mixtures: a step towards universal performance prediction model. The Drug Delivery to the Lungs 27th Conference, Edinburgh, Scotland, United Kingdom, 7-9 December 2016. New Rochelle, NY USA: Mary Ann Liebert Publishers.

Carrier microstructure and performance of dry powder inhalation mixtures: a step towards universal performance prediction model

2015

Journal Article

Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: carrier porosity and fine particle content

Shalash, Ahmed O., Molokhia, Abdulla M. and Elsayed, Mustafa M. A. (2015). Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: carrier porosity and fine particle content. European Journal of Pharmaceutics and Biopharmaceutics, 96, 291-303. doi: 10.1016/j.ejpb.2015.08.006

Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: carrier porosity and fine particle content